Spotlight on Student Research 2015-2016 - McGill University · PDF fileEBOH Spotlight on Student Research 2015-2016 Page 2 of 24 Publications 1. Acurcio FA , Machado MA, ... Scleroderma:

EBOHSpotlightonStudentResearch

2015-2016

EBOHSpotlightonStudentResearch2015-2016 Page2of24

Publications

1. AcurcioFA,MachadoMA,MouraCS,FerreF,GuerraJúniorAA,AndradeEI,CherchigliaML,RahmeE.MedicationpersistenceofDMARDsandanti-TNFagentsinacohortofpatientswithrheumatoidarthritisinBrazil.ArthritisCareRes(Hoboken).2016Jan27.doi:10.1002/acr.22840.

2. AcurcioFA,MouraCS,BernatskyS,BessetteL,RahmeE.OpioidUseandRiskofNonvertebralFracturesinAdultsWithRheumatoidArthritis:ANestedCase-ControlStudyUsingAdministrativeDatabases.ArthritisRheumatol.2016Jan;68(1):83-91.

3. AdiJ.Klil-Drori,LaurentAzoulayMichaelN.Pollak.(2016).CancerandDiabetes:HastheFogCleared?NatureReviewsClinicalOncology.[RevisionRequested].

4. AdiJ.Klil-Drori,FarzinKhosrow-KhavarSamySuissa.Re:Agreementoftreatmenteffectsformortalityfromroutinelycollecteddataandsubsequentrandomizedtrials:meta-epidemiologicalsurvey.BMJ2016;352:i493.

5. AdiJ.Klil-Drori,HuiYin,HaimA.Abenhaim,GuillaumeGalbaudduFort,andLaurentAzoulay.(2016).TheUseofProlactin-ElevatingAntipsychoticsandtheRiskofEndometrialCancer.JournalofClinicalPsychiatry.[InPress.]

6. AdiJ.Klil-Drori,HuiYin,VickyTagalakis,ArmenAprikian,LaurentAzoulay.(2015).Androgendeprivationtherapyforprostatecancerandtheriskofvenousthromboembolism.EuropeanUrology2015Jun29.pii:S0302-2838(15)00525-4.doi:10.1016/j.eururo.2015.06.022.[Epubaheadofprint.]

7. AdiJ.Klil-Drori,KorayTascilar,HuiYin,ArmenAprikian,AlainBittonMD,LaurentAzoulay.(2015).Androgendeprivationtherapyandtheincidenceofinflammatoryboweldiseaseinpatientswithprostatecancer.Americanjournalofepidemiology.[InPress.]

8. AdiJ.Klil-Drori,LaurentAzoulay.(2015).Theroleofselectionintheriskofbleedingwithdabigatraninpatientswithatrialfibrillation.JAMAInternalMedicine.2015Jul;175(7):1243-4.

9. AnemaA.,KarimM.E.,MilloyM.J.,WoodE.,McCandlessL."DirectedAcyclicGraphstoIdentifyConfounders:ACaseStudyExploringtheImpactofHungeronVirologicalSuppressionAmongHIV+IllicitDrugUsersReceivingHIVTreatment".In:HealthofHIVInfectedPeople:Food,NutritionandLifestylewithAntiretroviralDrugs[Volume1].WatsonRS(Ed.)2015.ElsevierPublishingInc.

10. AubouyA,OlagnierD,BertinG,EzinmegnonS,MajorelC,MimarS,MassougbodjiA,DeloronP,PipyB,CosteA.Nrf2-drivenCD36andHO-1geneexpressionincirculatingmonocytescorrelateswithfavourableclinicaloutcomeinpregnancy-associatedmalaria.MalarJ.2015 Sep18;14(1):358.doi:10.1186/s12936-015-0888-8

11. AuldSC,MooreBK,KyleRP,EngB,NongK,PevznerES,EamKK,EangMT,andKillamWP.MixedimpactofXpertMTB/RIFontuberculosisdiagnosisinCambodia.PublicHealthAction.AcceptedMarch1,2016.

12. AustinN,HarperS,KaufmanJ,HamraG.Challengesinreproducingresultsfrompubliclyavailabledata:anexampleofsexualorientationandcardiovasculardiseaserisk.JournalofEpidemiologyandCommunityHealth.2016:Onlinefirst.

13. AustinN,HarperS,StrumpfE.Estimatingtheimpactofracialresidentialsegregationonbirthweight:Aninstrumentalvariableapproach.Epidemiology(inpress).

14. AzarM,RiceD,KwakkenbosL,CarrierM-E,ShrierI,HudsonM,ThombsBD,SPINinvestigators.ExerciseHabitsandAssociatedFactorsinScleroderma:ASclerodermaPatient-centeredInterventionNetwork(SPIN)CohortStudy.JournalofSclerodermaandRelatedDiseases,1.PresentedinFebruary2016inLisbon,Portugal.

15. AzarM,RiehmKE,McKayD,ThombsBD.TransparencyofoutcomereportingandtrialregistrationofrandomizedcontrolledtrialspublishedintheJournalofConsultingandClinicalPsychology.PLoSONE10(11):e0142894.doi:10.1371/journal.pone.0142894

16. Azar,M.,Bodnar,M.,Malla,A.,Joober,R.,&Lepage,M.PrevalenceofPersistentNegativeSymptomsinAffectiveandNon-AffectivePsychosisDuringtheFirst12MonthsFollowingaFirstEpisodePsychosis.Abstractsforthe15thInternationalCongressonSchizophreniaResearch(ICOSR).SchizophreniaBulletin,41(Supplement1),S104.PresentedinMarch-April2015inColoradoSprings,Colorado.


17. BeljanskiV,ChiangC,KirchenbaumGA,OlagnierD,BloomCE,WongT,HaddadEK,TrautmannL,RossTM,HiscottJ.EnhancedInfluenzaVirus-LikeParticleVaccinationwithaStructurallyOptimizedRIG-I Agonist as Adjuvant. J Virol. 2015Oct;89(20):10612-24. doi: 0.1128/JVI.01526-15.Epub 2015Aug12.

18. BennettR,CerigoH,CoutléeF,RogerM,FrancoEL,BrassardP.Incidence,Persistence,andDeterminantsofHumanPapillomavirusInfectioninaPopulationofInuitWomeninNorthernQuebec.Sexuallytransmitteddiseases.2015;42(5):272-8.

19. Bernatsky,S.,Slim,Z.F.andYuwan,M.,2015.ACPAandFutureOnsetofRheumatoidArthritisAmongIndividualsWithUndifferentiatedArthritisandArthritisFreeIndividuals:ASystematicReviewofCohortStudies.JournalofAutoimmuneDiseasesandRheumatology,3(2),pp.30-40.

20. BjørnevikK.,RiiseT.,CorteseM.,HolmøyT.,KampmanM.T.,MagalhaesS.,MyhrK.M.,WolfsonC.,PugliattiM.(2016)Levelofeducationandmultiplesclerosisriskafteradjustmentforknownriskfactors:TheEnvIMSstudy.MultScler.22(1):104-11

21. BotnaruT,RobertA,MottilloS.IcatibantcomparedtosteroidsandantihistaminesforACE-inhibitor-inducedangioedema.CJEM.2016May;18:1-422. BrunetL,MoodieEEM,CoxJ,GillMJ,CooperC,WalmsleyS,RachlisA,HullM,KleinMB,fortheCanadianCoinfectionCohortStudyInvestigators.

OpioidsuseandriskofliverfibrosisinHIV/hepatitisCvirusco-infectedpatientsinCanada.HIVMed2016Jan;17(1):36-45.23. BrunetL,MoodieEEM,YoungJ,CoxJ,HullM,CooperC,WalmsleyS,Martel-LaferriereV,RachlisA,KleinMBfortheCanadianCoinfectionCohort

StudyInvestigators.ProgressionofliverfibrosisandmoderncombinationantiretroviraltherapyregimensinHIV-hepatitisCco-infectedpersons.ClinInfectDis.2016Jan15;62(2):242-9.

24. Burne,R.M.,Abrahamowicz,M.,"Martingaleresidual-basedmethodtocontrolforconfoundersmeasuredonlyinavalidationsampleintime-to-eventanalysis."StatisticsinMedicine(inpress)

25. CayaC,BoikosC,DesaiS,QuachC*.DosingRegimenofthe23-ValentPneumococcalVaccination:ASystematicReview.Vaccine2015;33:1302-12.26. CerigoH,Quesnel-ValleeA.Thesocialepidemiologyofsocio-economicinequalitiesindepression.InN.Cohen(Ed.),PublicHealthPerspectiveson

DepressiveDisorders.JohnsHopkinsUniversityPress,forthcoming.27. Chiang C, Beljanski V, Yin K,Olagnier D, Ben Yebdri F, Steel C, Goulet ML, DeFilippis VR,Streblow DN, Haddad EK, Trautmann L, Ross T,

Lin R, Hiscott J. Sequence-Specific ModificationsEnhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists. J Virol. 2015Aug;89(15):8011-25.doi:10.1128/JVI.00845-15.Epub2015May27.

28. ClarkS,Berrang-FordL,LwasaS,NamanyaD,TwesigomweS,IHACCResearchTeam,etal.(2016)ALongitudinalAnalysisofMosquitoNetOwnershipandUseinanIndigenousBatwaPopulationafteraTargetedDistribution.PLoSONE11(5):e0154808.doi:10.1371/journal.pone.0154808

29. ConstenlaD,ArmienB,ArredondoJ,CarabaliM,CarrasquillaG,CastroR,etal.CostingDengueFeverCasesandOutbreaks:RecommendationsfromaCostingDengueWorkingGroupintheAmericas.ValueinHealthRegionalIssues.8:80-91.PublishedDec.2015(http://www.sciencedirect.com/science/article/pii/S2212109915000473).

30. Coronado-MontoyaS,LevisAW,KwakkenbosL,SteeleRJ,TurnerEH,ThombsBD.ReportingofPositiveResultsinRandomizedControlledTrialsofMindfulness-BasedMentalHealthInterventions.PloSOne.2016Apr8;11(4):e0153220.

31. CorteseM.,RiiseT.,BjørnevikK.,HolmøyT.,KampmanM.T.,MagalhaesS.,PugliattiM.,WolfsonC.,MyhrK.M.(2015)Timingofuseofcodliveroil,avitaminDsource,andmultiplesclerosisrisk:TheEnvIMSstudy.MultScler.21(14):1856-64

32. CostiniukC,BrunetL,Rollet-KurhajecKC,CooperCL,WalmsleyS,GillMJ,Martel-LaferriereV,KleinMB.TobaccosmokingisnotassociatedwithacceleratedliverdiseaseinHIV-HepatitisCCo-infection:Alongitudinalcohortanalysis.OpenForumInfectDis.2016Mar;3(2):ofw050.

33. CoxJ,HamelinA-M,McLindenT,MoodieEEM,AnemaA,Rollet-KurhajecKC,ParadisG,RourkeSB,WalmsleySL,KleinMB.(2016).FoodInsecurityinHIV-HepatitisCVirusCo-infectedIndividualsinCanada:TheImportanceofCo-morbidities.AIDSandBehavior,InPress.

34. DayanN,SchlosserK,StewartD.J,OkanoM,Grand’MaisonS,PiloteL.CirculatingMicroRNAsProvideInsightIntoPotentialMolecularLinksBetweenHypertensiveDisordersofPregnancyandCardiovascularDisease.Circulation.2015;132:A15833.


35. DesforgesP,LeeT,McDonaldEG.Insomniainthehospital:notjustanightmare.TeachablemomentJAMAinternalmedicine.AcceptedforpublicationApril2016.

36. DesforgesP,LeeT,MurrayJ,McDonaldEG.Inmedicalinpatientstheoff-labeluseofquetiapineiscommonandcontinuespost-discharge.JAMAinternalmedicine.AcceptedforpublicationMay142016.

37. DimitrisMC,PerumalN,Craig-BarnesHA,LeadleyM,MahmudAA,BaquiAH,RothDE.Effectofweeklyhigh-dosevitaminD3supplementationonserumcholecalciferolconcentrationsinpregnantwomen.JSteroidBiochemMolBiol.2016Apr;158:76-81.

38. DollMK,BuckeridgeDL,MorrisonK,GagneurA,TapieroB,CharestH,QuachC*.EffectivenessofMonovalentRotavirusVaccineinaHigh-Income,PredominantUseSetting.Vaccine2015;33(51):7307-14.

39. DollMK,GagneurA,TapieroB,CharestH,GonzalesM,BuckeridgeDL,QuachC*.TemporalChangesinPediatricGastroenteritisFollowingRotavirusVaccinationinQuebec.PediatrInfect.DisJ2016Feb5[Epubaheadofprint

40. EmdinCA,MirF,SultanaS,KaziAM,ZaidiAKM,DimitrisMC,RothDE.UtilityandfeasibilityofintegratingpulseoximetryintotheroutineassessmentofyounginfantsatfirstlevelclinicsinKarachi,Pakistan:across-sectionalstudy.BMCPediatr.2015Sep30;15(1):141.

41. FoxGJ,LeeRS,LucasM,AhmadKhanF,ProulxJ-F,HornbyK,JungS,BenedettiA,BehrM,MenziesD.(2015).InadequatedietisassociatedwithacquiringMycobacteriumtuberculosisinfectioninanInuitcommunity:acase-controlstudy.AnnalsoftheAmericanThoracicSociety,DOI:10.1513/AnnalsATS.201503-156OC

42. Grand’MaisonS,PiloteL,DayanN.ImpactofGestationalComplicationsonSeverityandOutcomesFollowingAcuteCoronarySyndrome.CanJCardiol.2016;32(4):S8-9.

43. Grand’MaisonS,PiloteL,LandryT,OkanoM,DayanN.EndothelialDysfunctionAfterHypertensiveDisordersofPregnancy:aSystematicReviewandMeta-Analysis.SubmittedtoLancet2016/05/15

44. Grand’MaisonS,PiloteL,LandryT,OkanoM,DayanN.EndothelialDysfunctionAfterHypertensiveDisordersofPregnancy:aSystematicReviewandMeta-Analysis.JAmCollCardiol.2016;67(13-S):1861

45. Grand’MaisonS,PiloteL,LandryT,OkanoM,DayanN.EndothelialDysfunctionAfterHypertensiveDisordersofPregnancy:aSystematicReviewandMeta-Analysis.CanJCardiol.2016;32(4):S2.

46. GrandiSM,FilionKB,GervaisA,JosephL,O'LoughlinJ,ParadisG,PiloteL,RinfretS,and.EisenbergMJ,fortheZESCAInvestigators.TreatmentAdherenceandSmokingAbstinenceinPatientsPost-AcuteMyocardialInfarction.AmHeartJ.2016March;173:35-40.doi:10.1016/j.ahj.2015.12.003.Epub2015Dec17.

47. JohnsonSMA,BrophyJM.Mortalityriskofsotalolandamiodaroneforpost-CABGatrialfibrillation.IntJCardiol.2016;214:502-7doi:10.1016/j.ijcard.2016.04.032.

48. JohriM,PérezMC,ArsenaultC,SharmaJK,PantPaiN,PahwaS,SylvestreMP.Strategiestoincreasethedemandforchildhoodvaccinationindevelopingcountries:asystematicreviewandmeta-analysisBulletinoftheWorldHealthOrganization.2015May1;93(5):339-346C.

49. Karim,M.E.;Gustafson,P.(2016)"HypothesisTestingforanExposure-DiseaseAssociationinCase-ControlStudiesunderNon-differentialExposureMisclassificationinthepresenceofValidationData:BayesianandFrequentistAdjustments",StatisticsinBiosciences.DOI:10.1007/s12561-015-9141-9

50. Karim,M.E.;Gustafson,P.;Petkau,J.;Tremlett,H.andBeAMSstudygroup.(2016)"ComparisonofStatisticalApproachesDealingwithImmortalTimeBiasinDrugEffectivenessStudies"(acceptedinAmericanJournalofEpidemiology)

51. Kraicer-MelamedH,O’DonnellS,QuachC*.Theeffectivenessofpneumococcalpolysaccharidevaccine23(PPV23)inthegeneralpopulationof50yearsofageandolder:Asystematicreviewandmeta-analysis.Vaccine2016Mar18;34(13):1540-50.

52. KwakkenbosL,DelisleVC,FoxRS,GholizadehS,JewettLR,LevisB,MiletteK,MillsSD,MalcarneVL,ThombsBD.Psychosocialaspectsofscleroderma.RheumDisClinNorthAm.2015Aug;41(3):519-28.


53. KyleRP,MoodieEEM,KleinMB,AbrahamowiczM.Correctingformeasurementerrorintime-varyingcovariatesinmarginalstructuralmodels.AmJEpidemiol.AcceptedFeb.16,2016.

54. LabrecqueJA,KaufmanJS.Canaquasi-experimentaldesignbeabetterideathananexperimentalone?Epidemiology(aheadofprint)55. LaurinLPetal.Treatmentwithglucocorticoidsorcalcineurininhibitorsinprimaryfocalsegmentalglomerulosclerosis.ClinJAmSocNephrol.2016

Mar7;11(3):386-94.Aneditorialinthesameissuehighlightedtheworkfromthepaper:CohenJBandHoganJJ.Rethinkingfirst-lineimmunosuppressionforidiopathicFSGS.ClinJAmSocNephrol11:372-373,2016.

56. LeeRSandBehrMA.(2016)Doeschoicematter?Reference-basedalignmentformolecularepidemiologyoftuberculosis.JournalofClinicalMicrobiology,pii:JCM.00364-16

57. LeeRSandBehrMA.Theimplicationsofwholegenomesequencinginthecontroloftuberculosis(review).(2015).TherapeuticAdvancesinInfectiousDisease,DOI:10.1177/2049936115624630

58. LeeRS,RadomskiN,ProulxJ-F,LevadeI,ShapiroB.J.,McIntoshF,SoualhineH,MenziesD,BehrMA.(2015).PopulationgenomicsofMycobacteriumtuberculosisintheInuit.ProceedingsoftheNationalAcademyofSciencesUSA,112(44):13609-13614

59. LeeTC,McDonaldEG.DecipheringCholesterolTreatmentGuidelines:AClinician’sPerspective;lettertotheeditor.JAMA.2015Jun16;313(23):2381-2

60. LevisAW,HarelD,KwakkenbosL,CarrierME,MouthonL,PoiraudeauS,etal.UsingOptimalTestAssemblyMethodsforShorteningPatient-ReportedOutcomeMeasures:DevelopmentandValidationoftheCochinHandFunctionScale-6–ASclerodermaPatient-centeredInterventionNetwork(SPIN)CohortStudy.ArthritisCare&Research.2016Mar1.

61. LevisAW,LeentjensAF,LevensonJL,LumleyMA,ThombsBD.Comparisonofself-citationbypeerreviewersinajournalwithsingle-blindpeerreviewversusajournalwithopenpeerreview.JournalofPsychosomaticResearch.2015Dec31;79(6):561-5.

62. LevisB,AzarM,ThombsBD.DepressioninMedicalResidents.JAMA.[InPress].63. LevisB,AzarM,ThombsBD.DepressioninMedicalResidents.JAMA.2016;315(21):2347.64. LevisB,BenedettiA,LevisAW,IoannidisJPA,ShrierI,CuijpersP,GilbodyS,KlodaLA,65. LevisB,BenedettiA,LevisAW,IoannidisJPA,ShrierI,CuijpersP,etal.SelectiveCutoffReportinginStudiesofDiagnosticTestAccuracy:A

ComparisonofConventionalandIndividualPatientDataMeta-AnalysesofthePatientHealthQuestionnaire-9DepressionScreeningTool.AmericanJournalofEpidemiology.InPress.

66. LevisB,RiceDB,KwakkenbosL,SteeleR,HagedoornM,HudsonM,BaronM,ThombsBD,CanadianSclerodermaResearchGroup.Usingmaritalstatusandcontinuousmaritalsatisfactionratingstopredictdepressivesymptomsinmarriedandunmarriedwomenwithsystemicsclerosis.ArthritisCare&Research.[InPress].

67. Lian,Y.,Yin,H.,Pollak,M.N.,Carrier,S.,Platt,R.W.,Suissa,S.,&Azoulay,L.(2016).PhosphodiesteraseType5InhibitorsandtheRiskofMelanomaSkinCancer.EurUrol.Advanceonlinepublication.doi:10.1016/j.eururo.2016.04.035

68. LiuY,GouletML,SzeA,BelhadjS,LababidiR,BelgnaouiM,OlagnierD*,RongtuanL*.5’pppRNARIG-IagonistregulatesSTINGexpressionandprotectsagainstHSV-1infection.*Co-senior(UnderreviewinJournalofVirology)

69. LuY,AdamV,TeichV,BarkunA.TimingorDosingofIntravenousProtonPumpInhibitorsinAcuteUpperGastrointestinalBleedingHasLowImpactonCosts.TheAmericanjournalofgastroenterology.2016May3.

70. MagalhaesS.,PugliattiM.,CasettaI.,DrulovicJ.,GranieriE.,HolmøyT.,KampmanM.T.,LandtblomA-M,LauerK.,MyhrK-M.,ParpinelM.,PekmezovicT.,RiiseT.,WolfsonD.,ZhuB.,WolfsonC.(2015)TheEnvIMSStudy:DesignandMethodologyofanInternationalCase–ControlStudyofEnvironmentalRiskFactorsInMultipleSclerosis.Neuroepidemiology44(3):173-81.Mediacoverage:http://www.healio.com/pediatrics/gastrointestinal-conditions/news/online/%7B81cbf177-9a4c-46cf-8db7-31db3752ada8%7D/norovirus-driven-gastroenteritis-in-quebec-more-common-after-start-of-rotavirus-vaccine


71. McDonaldEG,BenmassaoudA*,LeeT.Potentialharmsofprotonpumpinhibitortherapy:rareadverseeffectsofcommonlyuseddrugs.CMAJ.2015Nov23.Epubaheadofprint.*co-firstauthor

72. McDonaldEG,DayanN,PelletierR,EisenbergM,PiloteL.HypertensiveDisordersofPregnancyandAngiographicFindingsinYoungWomenwithAcuteCoronarySyndrome.InternationalJournalofCardiology.AcceptedforpublicationMay2016.

73. McDonaldEG,GosselinS.LaPharmacothérapiedelaDependanceauTabacchezlaFemmeEnceinte.Critiqued’unarticled’intérêt.Bulletind’informationtoxicologique,May2015.

74. McDonaldEG,JonesJ,GreenL,JayaramanD,LeeTC.Reductionofinappropriateexitprescriptionsofprotonpumpinhibitors:abefore-afterstudyusingeducationpairedwithaweb-basedqualityimprovementtool.JHospMed,2015May;10(5):281-6.

75. McDonaldEG,LeeTC.Clostridiumdifficileinfection;Lettertotheeditor.NEnglJMed.2015Jul16;373(3):28676. McDonaldEG,LeeTC.Reductionofcentralvenouscathetersinhospitalizedpatientsusinganonlinetool.JAMAinternalmedicine.2015

Jul;175(7):1232-477. McDonaldEG,MilliganJ,FrenetteC,LeeTC.ContinuousprotonpumpinhibitortherapyandtheassociatedriskofrecurrentClostridiumDifficile.

JAMAintmed,2015May;175(5):784-91.78. McGregorK,SashaBernatsky,InesColmegna,MarieHudson,TomiPastinen,AurelieLabbe,CeliaMTGreenwood.Anevaluationofmethods

correctingforcelltypeheterogeneityinDNAmethylationstudies.GenomeBiologyMay2016.79. McMillanD,PattenSB,SteeleRJ,ZiegelsteinRC,BombardierCH,deLimaOsórioF,FannJR,GjerdingenD,LamersF,LotrakulM,LoureiroSR,Löwe

B,ShaabanJ,StaffordL,vanWeertHCPM,WhooleyMA,WilliamsLS,WittkampfKA,YeungAS,ThombsBD.Selectivecutoffreportinginstudiesofdiagnostictestaccuracy:Acomparisonoftraditionalandindividualpatientdatameta-analysesofthePatientHealthQuestionnaire-9depressionscreeningtool.AmericanJournalofEpidemiology.[InPress].

80. MerckxJ,McCormackD,QuachC*.ImprovingInfluenzaVaccinationinChronicallyIllChildrenusingaTertiary-CareBasedVaccinationClinic:IsthereaRolefortheLive-AttenuatedInfluenzaVaccine(LAIV)?Vaccine2016;34(6):750-6.

81. Metcalf TU, Cubas RA, Ghneim K, Cartwright MJ, Grevenynghe JV, Richner JM, OlagnierD,WilkinsonPA,CameronMJ, ParkBS,Hiscott JB,DiamondMS,WertheimerAM,Nikolich-Zugich J,HaddadEK.Globalanalysesrevealedage-relatedalterationsininnateimmuneresponsesafterstimulationof pathogen recognition receptors. Aging Cell. 2015 Jun;14(3):421-32. doi: 10.1111/acel.12320. Epub2015Feb27

82. MoqueetN,CooperC,GillMJ,HullM,PlattR,KleinMB,fortheCanadianCo-infectionCohort(CTN222).ResponderInterferonLambdagenotypesareassociatedwithhigherriskofliverfibrosisinHIV-HepatitisCVirusCo-infection.JInfectDis2016.http://goo.gl/NEqMNp

83. MoqueetN,Infante-RivardC,PlattRW,YoungJ,CooperC,HullM,WalmsleyS,KleinMB,fortheCanadianCoinfectionCohortStudyInvestigators(CTN222).FavourableIFNL3GenotypesAreAssociatedwithSpontaneousClearanceandareDifferentiallyDistributedinAboriginalsinCanadianHIV-HepatitisCCo-InfectedIndividuals.IntJMolSci.2015Mar20;16(3):6496-512.

84. MorrisonKT,ShaddickG,HendersonSB,BuckeridgeDL.2016.'Alatentprocessmodelforforecastingmultipletimeseriesinenvironmentalpublichealthsurveillance.'StatisticsinMedicine.DOI10.1002/sim.6904.

85. MottilloS,AfilaloM,BoivinJF,ColaconeA,DelaneyJS,JourdenaisE,MoraisJA,TroquetJM,XiaoqingX,AfilaloJ.Frailtyasapredictorofrepeatemergencydepartmentvisitsanddisabilityintheelderly:apilotstudy.CJEM2015;17:S4.

86. MottilloS,BoyleP,JacobiCadeteLD,RouleauJL,EisenbergMJ.Anationalsurveyofmentoringpracticesforyounginvestigatorsincirculatoryandrespiratoryhealth.CanRespirJ.2016Jan;23(1):1-8.

87. MottilloS,FilionKB,JosephL,EisenbergMJ.Definingoptimalactivatedclottingtimeforpercutaneouscoronaryintervention:asystematicreviewandBayesianmeta-regression.CatheterCardiovascInterv.2016Mar.

88. MouraCS,AbrahamowiczM,BeauchampME,LacailleD,WangY,BoireG,FortinPR,BessetteL,BombardierC,WiddifieldJ,HanlyJG,FeldmanD,MaksymowychW,PeschkenC,BarnabeC,EdworthyS,BernatskyS;CAN-AIM.Earlymedicationuseinnew-onsetrheumatoidarthritismaydelay


jointreplacement:resultsofalargepopulation-basedstudy.ArthritisResTher.2015Aug3;17:197.89. MouraCS,DaskalopoulouSS,LevesqueLE,BernatskyS,AbrahamowiczM,TsadokMA,RajabiS,PiloteL.ComparisonoftheEffectofThiazide

DiureticsandOtherAntihypertensiveDrugsonCentralBloodPressure:Cross-SectionalAnalysisAmongNondiabeticPatients.JClinHypertens(Greenwich).2015Nov;17(11):848-54.

90. OlagnierD,AmatoreD,Castiello L, FerrariM,PalermoE,DiamondMS,PalamaraAT,Hiscott J.Dengue Virus Immunopathogenesis: LessonsApplicable to the Emergence of Zika Virus. JMol Biol.2016Apr27.pii:S0022-2836(16)30083-3.doi:10.1016/j.jmb.2016.04.024.[Epubaheadofprint]Review.

91. Olagnier D, Chiang C, Hiscott J. Evaluation of innate immune gene expression following HDACinhibitortreatmentbyPhosFlowcytometryandhighthroughputqPCR.(AcceptedinMethods inMolecularBiology)

92. PangY,DuJ,QinZZ,GreenwaldZ,LiuY,MiF,ZhaoY,LiL.Anoverviewontuberculosis-specifichospitalsinChinain2009:resultsofanationalsurvey.EurRespirJ.2016Feb25.pii:ERJ-01854-2015.doi:10.1183/13993003.01854-2015.[Epubaheadofprint]

93. RenouxC,ShinJY,Dell'AnielloS,FergussonE,SuissaS.PrescribingTrendsofAttention-DeficitHyperactivityDisorder(ADHD)MedicationsinUKPrimaryCare,1995-2015.BrJClinPharmacol.2016May4.doi:10.1111/bcp.13000.[Epubaheadofprint]

94. RiceDB,KlodaLA,LevisB,QiB,KingslandE,ThombsBD.AreMEDLINESearchesSufficientforSystematicReviewsandMeta-analysesoftheDiagnosticAccuracyofDepressionScreeningTools?AReviewofMeta-analyses.JournalofPsychosomaticResearch.[InPress].

95. RiddeV,AgierI,BonnetE,CarabaliM,DabiréKR,FournetF,etal.PresenceofthreedengueserotypesinOuagadougou(BurkinaFaso):researchandpublichealthimplications.InfectiousDiseasesofPoverty.2016;5(1):1-13.PublishedApril2016.(https://idpjournal.biomedcentral.com/articles/10.1186/s40249-016-0120-2)

96. RiehmKE,AzarM,ThombsBD.Transparencyofoutcomereportingandtrialregistrationofrandomizedcontrolledtrialsintoppsychosomaticandbehaviouralhealthjournals:A5-yearfollow-up.JournalofPsychosomaticResearch.2015;79(1):1-12.

97. RossiC,CoxJ,CooperC,Martel-LaferrièreV,WalmsleyS,GillJ,Sapir-PichhadzeR,MoodieEEM,KleinMB.FrequentinjectioncocaineuseincreasestheriskofrenalimpairmentamonghepatitisCandHIVco-infectedpatients.AIDS2016Jun1;30(9):1403-311.

98. RothDE,GernandAD,MorrisSK,PezzackB,IslamM,DimitrisMC,ShantaSS,ZlotkinSH,WillanAR,AhmedT,ShahPS,MurphyKE,WeksbergR,ChoufaniS,ShahR,MahmudAA.(2015).MaternalvitaminDforinfantgrowth(MDIG):studyprotocolforarandomizedcontrolledtrialofvitaminDsupplementationduringpregnancyandlactationinDhaka,Bangladesh.Trials.2015Jul14;16:300.

99. SaeedS,StrumpfEC,WalmsleySL,Rollet-KurhajecK,PickN,Martel-LaferrièreV,HullM,GillMJ,CoxJ,CooperC,KleinMB;CanadianCo-InfectionCohortStudy.HowGeneralizableAretheResultsFromTrialsofDirectAntiviralAgentstoPeopleCoinfectedWithHIV/HCVintheRealWorld?ClinicalInfectiousDiseases.2016Apr1;62(7):919-26.(ImpactFactor8.9)

100. ShamL.,YehE.A.,MagalhaesS.,ParraE.,GozdzikA.,BanwellB.,HanwellH.E.(2015)EvaluationofafallsunexposurescoreinpredictingvitaminDstatusinyoungCanadianadults,andtheinfluenceofancestry.JPhotochemPhotobiolB.145:25-9.

101. ShapiroGD,BushnikT,SheppardAJ,KramerMS,KaufmanJS,YangS.MissingpaternaldataandadversebirthoutcomesinCanada.HealthRep.102. ShapiroGD,BushnikT,SheppardAJ,KramerMS,KaufmanJS,YangS.PaternalEducationandAdverseBirthOutcomesinCanada.JEpidemiol

CommunityHealth.103. ShiraniA.,Zhao,Y.PetkauJ.,GustafsonP.,KarimM.E.,EvansC.,KingwellE.,vanderKopM.L.,Ogerj.andTremlettH.(2015)"Multiplesclerosisin

olderadults:theclinicalprofileandimpactofinterferonbetatreatment",BioMedResearchInternational.DOI:10.1155/2015/451912104. SoongC,LeisJ,OkrainecK,McDonaldEG,LeeTC.Apointprevalencestudyofurinarycatheteruseamongteachinghospitalswithandwithout

reductionprograms.JHospMed.AcceptedforpublicationMay2016


105. SuissaK,EisenbergMJ,GrandiSM,JosephL,O'LoughlinJ,ParadisG,FilionKBfortheZESCAInvestigators.TheEffectofBupropiononSymptomsofDepressionAmongPatientsAttemptingtoQuitSmokingPost-MyocardialInfarction:TheZESCATrial.SubmittedtoJournalofPopulationTherapeuticsandClinicalPharmacology.

106. SyrowatkaA,KrömkerD,MeguerditchianAN,TamblynR.Featuresofcomputer-baseddecisionaids:systematicreview,thematicsynthesis,andmeta-analyses.JournalofMedicalInternetResearch2016;18(1):e20.

107. ThombsBD,BenedettiA,KlodaLA,LevisB,AzarM,RiehmKE,SaadatN,CuijpersP,GilbodyS,IoannidisJPA,McMillanD,PattenSB,ShrierI,SteeleRJ,ZiegelsteinRC,LoiselleCG,HenryM,IsmailZ,MitchellN,TonelliM.TheDiagnosticAccuracyoftheDepressionSubscaleoftheHospitalAnxietyandDepressionScale(HADS-D)forDetectingMajorDepression:ProtocolforaSystematicReviewandIndividualPatientDataMeta-analyses.BMJOpen.[InPress].

108. ThombsBD,BenedettiA,KlodaLA,LevisB,AzarM,RiehmKE,SaadatN,CuijpersP,GilbodyS,IoannidisJP,McMillanD,PattenSB,ShrierI,SteeleRJ,ZiegelsteinRC,LoiselleCG,HenryM,IsmailZ,MitchellN,TonelliM.DiagnosticaccuracyoftheDepressionsubscaleoftheHospitalAnxietyandDepressionScale(HADS-D)fordetectingmajordepression:protocolforasystematicreviewandindividualpatientdatameta-analyses.BMJOpen.2016Apr13;6:e011913.

109. ThombsBD,BenedettiA,KlodaLA,LevisB,RiehmKE,AzarM,CuijpersP,GilbodyS,IoannidisJPA,McMillianD,PattenSB,ShrierI,SteeleRJ,ZiegelsteinRC,TonelliM,MitchellN,ComeauL,SchinaziJ,VigodS.ThediagnosticaccuracyoftheEdinburghPostnatalDepressionScale(EPDS)fordetectingmajordepressioninpregnantandpostnatalwomen:Protocolforasystematicreviewandindividualpatientdatameta-analyses.BMJOpen.2015;5:e009742doi:10.1136/bmjopen-2015-009742;52015.

110. ThombsBD,BenedettiA,KlodaLA,LevisB,RiehmKE,AzarM,CuijpersP,GilbodyS,IoannidisJPA,McMillanD,PattenSB,ShrierI,SteeleRJ,ZiegelsteinRC,TonelliM,MitchellN,ComeauL,SchinaziJ,VigodS.DiagnosticaccuracyoftheEdinburghPostnatalDepressionScale(EPDS)fordetectingmajordepressioninpregnantandpostnatalwomen:protocolforasystematicreviewandindividualpatientdatameta-analyses.BMJOpen.2015Oct;5:e009742.

111. ThrallS,DollMK,NhanC,GonzalesM,PerreaultT,LamerP,QuachC*.EvaluationofRotavirusVaccinationinNeonatalIntensiveCareUnits.Vaccine2015;33(39):5095-5102.

112. TranT,BrophyJM,SuissaS,RenouxC.RisksofCardiacValveRegurgitationandHeartFailureAssociatedwithErgot-andNon-Ergot-DerivedDopamineAgonistUseinPatientswithParkinson'sDisease:ASystematicReviewofObservationalStudies.CNSDrugs.2015Dec;29(12):985-98.

113. TuccoriM,WuJW,YinH,MajdanA,&AzoulayL.Theuseofglyburidecomparedwithothersulfonylureasandtheriskofcancerinpatientswithtype2diabetes.(2015).Diabetescare,38(11),2083-2089.(http://www.ncbi.nlm.nih.gov/pubmed/26341130)

114. VillandreL,StephensDA,LabbeA,GünthardHF,KouyosR,etal.(2016)AssessmentofOverlapofPhylogeneticTransmissionClustersandCommunitiesinSimpleSexualContactNetworks:ApplicationstoHIV-1.PLoSONE11(2):e0148459.doi:10.1371/journal.pone.0148459

115. Wang,Y.,Murphy,O.,Turgeon,M.,Wang,Z.Y.,Bhatnagar,S.R.,Schulz,J.,andMoodie,E.E.M.“Theperilsofquasi-likelihoodinformationcriteria”,Stat,4:2015.doi:10.1002/sta4.95

116. WiddifieldJ,MouraCS,WangY,AbrahamowiczM,PatersonJM,HuangA,BeauchampME,BoireG,FortinPR,BessetteL,BombardierC,HanlyJG,FeldmanD,BernatskyS;CAnadianNetworkforAdvancedInterdisciplinaryMethodsforcomparativeeffectivenessresearch(CAN-AIM).TheLongtermEffectofEarlyIntensiveTreatmentofSeniorswithRheumatoidArthritis:AComparisonof2Population-basedCohortStudiesonTimetoJointReplacementSurgery.JRheumatol.2016May;43(5):861-8.doi:10.3899/jrheum.151156.Epub2016Feb15.

117. WongJ,MotulskyA,EgualeT,BuckeridgeDL,AbrahamowiczM,TamblynR.TreatmentindicationsforantidepressantsprescribedinprimarycareinQuebec,Canada,2006-2015.JournaloftheAmericanMedicalAssociation.Accepted9Mar2016.TobepublishedonMay24,2016.

118. WuJW,FilionKB,AzoulayL,DollMK,andSuissaS.Effectoflong-actinginsulinanalogsontheriskofcancer:asystematicreviewofobservationalstudies.(2016).DiabetesCare,39(3),486-94.(http://www.ncbi.nlm.nih.gov/pubmed/26740633)


119. XiongX,JohnsonT,JayaramanD,McDonaldEG,MartelM,BarkunA.Atthecrossroadswithmorbidityandmortalityconferences:lessonslearnedthroughanarrativesystematicreview.Clinicaljournalofgastroenterologyandhepatology.September2015.Acceptedforprintaheadofpublication.

120. Yanling;Cai,Jing;Chen,Jessica;Golchi,Shirin;Guan,Meijiao;Karim,M.E.;Liu,Yang;Tomal,Jabed;Xiong,Chao;Zhai,Yongliang;Lum,Conroy;Welch,W.J.;Zidek,JamesV.(2016)"Anempiricalexperimenttoassesstherelationshipbetweenthetensileandbendingstrengthsoflumber",Technicalreport276,DepartmentofStatistics,UniversityofBritishColumbia.

121. Zhang,T.;Shirani,A.;Zhao,Y.;Karim,M.E.;Gustafson,P.;Petkau,J.;Evans,C.;Kingwell,E.;vanderKop,M.;Zhu,F.;Oger,J.;Tremlett,H.(2015)"Beta-interferonexposureandonsetofsecondaryprogressivemultiplesclerosis",EuropeanJournalofNeurology.DOI:10.1111/ene.12698

122. ZinszerK,MorrisonK,AnemaA,MajumderMS,BrownsteinJS.2015.'ThevelocityofEbolaspreadinpartsofwestAfrica.’TheLancetInfectiousDiseases.15(9):1005-7.


Presentations

1. AdiKlil-Drori(2015).Androgendeprivationtherapyandtheriskofvenousthromboembolism.AmericanSocietyforClinicalOncologyAnnualMeeting2015,Chicago,UnitedStates.

2. AdiKlil-Drori(2015).Androgendeprivationtherapyandtheriskofautoimmunediseases.AmericanSocietyforClinicalOncologyAnnualMeeting2015,Chicago,UnitedStates.

3. AdiKlil-Drori(2015).Androgendeprivationtherapyforprostatecancerandtheriskofvenousthromboembolism.AnnualcongressoftheUrologicalAssociationofQuébec,Montreal,Canada.

4. AdiKlil-Drori(2015).Androgendeprivationtherapyforprostatecancerandtheriskofvenousthromboembolism.Androgendeprivationtherapyandtheincidenceofautoimmunediseases.InternationalConferenceofPharmacoepidemiology,Boston,UnitedStates.

5. AdiKlil-Drori(2015).Androgendeprivationtherapyforprostatecancerandtheincidenceofinflammatoryboweldisease.McGillResearchDay,Montreal,Canada.

6. AdiKlil-Drori(2015).Comparativeeffectivenessofbrand-nameandgenericimatinibforthetreatmentofchronicmyeloidleukemia.AmericanSocietyofHematology2015,Orlando,UnitedStates.

7. AdiKlil-Drori(2015).ExtendedDurationsofAnticoagulationfollowingIncidentVenousThromboembolismandMortalityintheQ-VTECohort.XXVCongressoftheInternationalSocietyofThrombosisandHemostasis,Toronto,Canada.

8. AdiKlil-Drori(2015).Theuseofprolactin-elevatingantipsychoticsandtheriskofendometrialcancer.CanadianCancerResearchConference,Montreal,Canada.

9. AdiKlil-Drori(2016)Pioglitazoneandtheriskofprostatecancer.AmericanSocietyforClinicalOncologyAnnualMeeting2016,Chicago,UnitedStates.10. AdiKlil-Drori(2016).Outpatientmanagementofpulmonaryembolismincancerpatients:Amatched-cohortanalysis.AmericanSocietyforClinical

OncologyAnnualMeeting2016,Chicago,UnitedStates.11. ArsenaultC,HarperS,NandiA,MendozaRodríguezJM,HansenP,JohriM.Equitymeasurementinthepost-2015:asystematicanalysisof

inequalitiesinvaccinationcoverageinGAVI-supportedcountries.PosterpresentationattheSeventhannualconferenceoftheConsortiumofUniversitiesforGlobalHealth.April9-11,2016,SanFrancisco,California,USA.

12. ArsenaultC,HarperS,NandiA,MendozaRodríguezJM,HansenP,JohriM.Monitoringequityinchildhoodvaccinationcoverage:asystematicanalysisof45demographicandhealthsurveys.Posterpresentationatthe22ndCanadianConferenceonGlobalHealth.November5-7,2015,Montreal,Canada.

13. AustinN,HarperS,KaufmanJS,HamraG.(2016).Challengesinreproducingresultsfrompubliclyavailabledata:anexampleofsexualorientationandcardiovasculardiseaserisk.Posterpresentation:PopulationAssociationofAmerica(PAA)2016AnnualMeeting,WashingtonDC,UnitedStates

14. AustinN,HarperS.(2016).TRAPlawsandabortionrates:Dorestrictionsmatter?Posterpresentation:2016EpidemiologyCongressoftheAmericas,Miami,UnitedStates

15. AustinN,HarperS.(2016).TRAPlawsandabortionrates:Dorestrictionsmatter?Posterpresentation:PopulationAssociationofAmerica(PAA)2016AnnualMeeting,WashingtonDC,UnitedStates

16. AzarM,BodnarM,MallaA,JooberR,LepageM.DeterminingthePrevalenceofPersistentNegativeSymptomsinAffectiveandNon-AffectivePsychosisDuringtheFirst12MonthsFollowingaFirstEpisodePsychosis.15thInternationalCongressonSchizophreniaResearch(ICOSR),ColoradoSprings,Colorado,March-April,2015.

17. AzarM,RiceD,HudsonM,KwakkenbosL,ThombsBD,SPINInvestigators.ExerciseHabitsanditsAssociatedFactorsinScleroderma.2015SclerodermaNationalConference,SclerodermaSocietyofCanada,Hamilton,Ontario,September19,2015.


18. AzarM,RiceD,KwakkenbosL,CarrierM-E,ShrierI,HudsonM,ThombsBD,SPINinvestigators.ExerciseHabitsandAssociatedFactorsinScleroderma:ASclerodermaPatient-centeredInterventionNetwork(SPIN)CohortStudy.47thLaurentianConferenceofRheumatology,Estérel,Quebec,May2016.

19. AzarM,RiceD,KwakkenbosL,CarrierM-E,ShrierI,HudsonM,ThombsBD,SPINinvestigators.ExerciseHabitsandAssociatedFactorsinScleroderma:ASclerodermaPatient-centeredInterventionNetwork(SPIN)CohortStudy.4thSystemicSclerosisWorldCongress,Lisbon,Portugal,February2016.

20. AzarM,RiehmKE,McKayD,ThombsBD.TransparencyofoutcomereportingandtrialregistrationofrandomizedcontrolledtrialspublishedintheJournalofConsultingandClinicalPsychology.2016EpidemiologyCongressoftheAmericas,Miami,Florida,USA,June2016.

21. AzarM,RiehmKE,McKayD,ThombsBD.TransparencyofoutcomereportingandtrialregistrationofrandomizedcontrolledtrialspublishedintheJournalofConsultingandClinicalPsychology.LadyDavisInstituteforMedicalResearch(LDI)ResearchRetreat,JewishGeneralHospital,McGillUniversity.Montreal,Quebec,June2016.

22. AzarM,RiehmKE,McKayD,ThombsBD.TransparencyofoutcomereportingandtrialregistrationofrandomizedcontrolledtrialspublishedintheJournalofConsultingandClinicalPsychology.12thAnnualResearchDayoftheDepartmentofEpidemiology,BiostatisticsandOccupationalHealthofMcGillUniversity,Montreal,Quebec,April2016.

23. AzarM,RiehmKE,SaadatN,FedorukC,KimmelmanJ,LevisB,LevisAW,RiceDB,KlodaLA,ThombsBD.TransparencyofOutcomeReportingandTrialRegistrationofRandomizedControlledTrialsofNon-RegulatedHealthInterventions.PreventingOverdiagnosis2016,Barcelona,Spain.September2016.

24. Behlim,T.,Basso,O.,&Yang,S.(June2016)DifferencesinbirthweightbymaternalandpaternalnativityinCanada.PosterpresentedattheannualmeetingoftheSocietyforPediatricandPerinatalEpidemiologicResearch,Miami,FL.

25. BoikosC,CharestH,PapenburgJ,ScheifeleD,LandsLC,DeSerresG,QuachC*.SheddingofLive-AttenuatedInfluenzaVaccine(LAIV)VirusesinCanadianChildrenandAdolescentswithandwithoutCysticFibrosis.CanJInfectDisMedMicrobiol.2015;26:e17.***WinneroftheSusanKingAward(2015–AMMICanadaAnnualConference)

26. BoikosC,DeSerresG,LandsLC,ScheifeleG,BoucherFD,ChilversM,DaigneaultQuachC*.SafetyoftheLive-AttenuatedIntranasalInfluenzaVirus(LAIV)VaccineinChildrenandAdolescentswithCysticFibrosisandtheirHealthySiblings.CanJInfectDisMedMicrobiol2015;26:e42.

27. BrunetL,MoodieEEM,YoungJ,WalmsleyS,HullM,CooperC,KleinMBfortheCanadianCo-infectionCohortStudy(CTN222).Changesinamarkerofliverfibrosisamongproteaseinhibitor(PI)andnon-nuleosidereversetranscriptaseinhibitor(NNRTI)usersintheCanadianCo-infectionCohort.19thWorkshoponHIVObservationalDatabases,Catania,Sicily,Italy.26-28thMarch2015.(poster)

28. BrunetL,MoodieEEM,YoungJ,WalmsleyS,HullM,CooperC,KleinMBfortheCanadianCo-InfectionCohortStudyInvestigators(CTN222).AlongitudinalanalysisofliverfibrosisprogressionamongNNRTIandPIusersintheCanadianCo-infectionCohortStudy.8thIASConferenceonHIVPathogenesis,TreatmentandPrevention.Vancouver,BritishColumbia.July19-22,2015.(oralpresentation)(featuredonHIVandHepatitis.com:http://goo.gl/SNdnRv)

29. BurneR,AbrahamowiczM.“Martingaleresidual-basedmethodsforusingvalidationsubsamplestoadjustfortime-dependentunmeasuredconfoundersinsurvivalanalysis.”AnnualConferenceoftheInternationalSocietyforClinicalBiostatistics.Utrecht,Netherlands.23-27August2015.

30. BurneR,AbrahamowiczM.“NewStatisticalMethodsforusingValidationSubsamplestoadjustforTime-DependentUnmeasuredConfoundersinMarginalStructuralCoxModels.”InternationalConferenceonPharmacoepidemiology&TherapeuticRiskManagement.Dublin,Ireland.25-28August2016(Acceptedfororalpresentation).**awardedtheEdlavitchawardforbeststudentabstract.

31. CantorT,AndermannAonbehalfoftheCLEARCollaboration.CLEARtoolkitadvancedpilotstudy:Helpinghealthworkersaddressthesocialcausesofpoorhealth.CanadianAssociationforHealthServicesandPolicyResearch(CAHSPR)2016Conference.Toronto,Canada:May2016.


32. CarabaliM,KaufmanJS."Burdenofinfectiousdiseases:thecontributionofsocialdeterminantsofhealth".TomlinsonTalks.UniversityClub.Montreal(QC),Canada.April13th,2016.

33. CarabaliM,LimJK,BarroA,OuobaA,MunozM,CampaoreB,LeeKS,LeeJS,BonnetEB,RiddeV,SeydouY."DengueVaccineInitiative:PassivefeversurveillanceandserologicalsurveyfordengueinOuagadougou,BurkinaFaso".ASTMH64thAnnualMeeting,October25-29,2015.Philadelphia,Pennsylvania,USA.7.LeeKS,LimJK,CarabaliM,ParkJinKyung.UseofInternetApplicationsinDataManagementoftheDengueVaccineInitiativefieldstudies.ASTMH64thAnnualMeeting,October25-29,2015.Philadelphia,Pennsylvania,USA.

34. CarabaliM,LimJK,DahourouD,KagoneST,NikiemaTJ,BarroSA,RiddeV,YaroS.“BurdenofdengueinfectioninchildrenandadultsofOuagadougou,BurkinaFaso”.18thJourneesdesSciencedelaSantedeBobo-Dioulasso.May5,2016.Bobo-Dioulasso,BurkinaFaso.

35. CarabaliM,LimJK,PalenciaD,LeeKS,LeeJS,LozanoA,HerreraVM,RojasE,VillarLA."DengueVaccineInitiativeproject:BurdenofdenguefeverinchildrenandadultsofPiedecuesta-Santander,Colombia".ASTMH64thAnnualMeeting,October25-29,2015.Philadelphia,Pennsylvania,USA.

36. CarabaliM.“FeverSurveillanceanddengueBurdeninColombia”.3rdInternationalDengueCourse.August10-13,2016.(http://www.redaedes.org/english/curso.php)

37. CerigoH,Quesnel-ValléeA.InequalitiesinaccesstohealthcareamongOECDcountries.RRSPQJournéeScientifique.Montreal,March,2016(oral,invited).

38. CerigoH,Quesnel-ValléeA.InequalitiesinaccesstohealthcareamongOECDcountries.22ndInternationalConferenceofEuropeanists.Paris,July,2015(oral).

39. CerigoH,Quesnel-Vallée.InequalitiesinunmetneedsinselectEuropeanandCommonwealthcountries:Theroleofhealthsystemfinancingcharacteristics.SparkingSolutionsSummit.April2016.OttawaON(poster).

40. ChangS-L,SyrowatkaA,MayoN,TamblynR,MeguerditchianAN.Psychotropicandnarcoticdruguseinolderwomendiagnosedwithbreastcanceracrossthecancercaretrajectory.Podiumpresentationatthe21stInternationalConferenceonPalliativeCareinMontreal,QConOctober19,2016[accepted].

41. ChongJ,LévesqueS,BlanchardAC,LaferriereC,QuachC*.MolecularEpidemiologyofVancomycinHeteroresistantCoagulase-NegativeStaphylococciinaNeonatalIntensiveCareUnitinQuebec.CanJInfectDisMedMicrobiol2015;26:e40.

42. CristianoMoura,SashaBernatsky,YvanSt.Pierre,SusanScott,ChristianA.Pineau,AnnE.ClarkeandEvelyneVinet.IncreasedDirectHealthcareCostsinSLEPregnancies.AnnualMeetingofAmericanCollegeofRheumatology,SanFrancisco,USA.November,2015

43. CristianoSMoura,ElhamRahme,WalterP.Maksymowych,MichalAbrahamowicz,LouisBessette,SashaBernatsky.Riskofhospitalizedseriousinfectioninankylosingspondylitis(AS)patientsusingnon-biologicDMARDsorAnti-TNFagents.AnnualEuropeanCongressofRheumatology,Rome,Italy.June2015

44. DeL’Étoile-MorelS,McDonaldEG,LeeTC.Communityacquiredpneumonia:possibilitiesforimprovement.Posterpresentation,AssociationofMedicalMicrobiologyandInfectiousdiseasesCanada,April2015,CharlottetownPEI.

45. DesforgesP,MurrayJ,LeeT,McDonaldEG.Seroquelforsleep: lessismore.LownInstituteRightCareConference,oralpresentation,ChicagoIllinois,April2016.

46. Graham,E.,Au,B.,Schmitz,N.'Depressivesymptoms,prediabetes,andincidentdiabetesinanEnglishcommunitysample.CongressoftheAmericas,Miami,FL,June2016.

47. Graham,E.,Gariépy,G.,Burns,R.J.,Schmitz,N.ModifiableLifestyleCharacteristicsofOlderEnglishAdultswithPrediabetes.SocietyforEpidemiologicResearch48thAnnualMeeting,Denver,CO,June2015.

48. Grand’MaisonS,etal.DeterminantsofSmokingCessationinYoungWomenandMenAfterAcuteCoronarySyndrome.CanadianCardiovascularCongress.Toronto,On.Octobre2015.


49. Grand’MaisonS,etal.DeterminantsofSmokingCessationinYoungWomenandMenAfterAcuteCoronarySyndrome.McGillCardiovascularResearchDay.Montréal,Qc.Mai2015.

50. Grand’MaisonS,etal.EndothelialDysfunctionAfterHypertensiveDisordersofPregnancy:aSystematicReviewandMeta-Analysis.CanadianWomen’sHeartHealthSummit.Ottawa,On.Avril2016.

51. Grand’MaisonS,etal.EndothelialDysfunctionAfterHypertensiveDisordersofPregnancy:aSystematicReviewandMeta-Analysis.AmericanCollegeofCardiologyScientificSessions.Chicago,Ill.Avril2016(“moderatedposter”).

52. Grand’MaisonS,etal.ImpactofGestationalComplicationsonSeverityandOutcomesFollowingAcuteCoronarySyndrome.CanadianWomen’sHeartHealthSummit.Ottawa,On.Avril2016.

53. Grand’MaisonS,etal.SexDifferencesinClinicalOutcomesAfterPrematureAcuteCoronarySyndrome.CanadianCardiovascularCongress.Toronto,On.Octobre2015.

54. Grand’MaisonS,etal.WithdrawalfromtheWorkforceFollowingPrematureAcuteCoronarySyndrome:SexDifferencesandDeterminants.McGillCardiovascularResearchDay.Montréal,Qc.Mai2015.

55. Grand’MaisonS,etal.WithdrawalfromtheWorkforceFollowingPrematureAcuteCoronarySyndrome:SexDifferencesandDeterminants.CanadianCardiovascularCongress.Toronto,On.Octobre2015.

56. GrandiSM,Vallée-PouliotK,EbergM,PlattRW,ArelR,BassoO,FilionKB.Hypertensivedisordersinpregnancyandtheriskofincidentcardiovasculardisease:theimpactoftime-varyingconfounding.PresentedattheSocietyforPediatricandPerinatalEpidemiologicResearchandtheSocietyforEpidemiologicResearch.June14-19,2015.Denver,CO.

57. GrandiSM,Vallée-PouliotK,EbergM,PlattRW,ArelR,FilionKB.HypertensiveDisordersinPregnancyandtheRiskofIncidentCardiovascularDisease.McGillUniversity,DepartmentofEpidemiology,Biostatistics,andOccupationalHealthStudentResearchDay.April24,2015.**Awardedbestposterpresentation.

58. GravelC.JointStatisticalMeetings2016-"Weightedestimationinconfoundedbinarydatasubjecttooutcomemisclassification"(accepted)59. GravelC.MisclassifiedRightCensoredContinuousTimeSurvivalData"60. GravelC.StatisticalSocietyofCanadaAnnualmeeting2015-"AValidationSamplingApproachforUnbiasedEstimationin61. GravelC.StatisticalSocietyofCanadaAnnualmeeting2016-"InverseProbabilityWeightedEstimationinConfoundedBinaryDatawithOutcome

Misclassification"(accepted)62. GreenwaldZR.,FregnaniJ.H.,Longatto-FilhoA.,WatanabeA.,VazquezF.L.,deCastroMattosJ.,MauadE.C.,FrancoE.L.“Evaluatingtheperformance

ofmobileunitsinabreastcancerscreeningprograminSãoPaulo,Brazil”Presentedat:NationalCancerInstitute,GlobalCancerSymposium,SanFrancisco,USA,April8,2016;

63. GreenwaldZR.,FregnaniJ.H.,Longatto-FilhoA.,WatanabeA.,VazquezF.L.,deCastroMattosJ.,MauadE.C.,FrancoE.L.“EvaluatingtheperformanceofmobileunitsinabreastcancerscreeningprograminSãoPaulo,Brazil”Upcomingpresentationat:InternationalAgencyforResearchonCancer(IARC)conference,Lyon,France,June7–10,2016

64. Karim,M.E.;Gustafson,P.;Petkau,J.;Tremlett,H.;TheBeAMSstudygroup"ComparisonofStatisticalApproachesDealingwithImmortalTimeBiasinDrugEffectivenessStudies",sessionon"BiostatisticsinAction1",AnnualMeetingoftheStatisticalSocietyofCanada,DalhousieUniversity,Halifax,NovaScotia,June14-17,2015.

65. Karim,M.E.;Pang,M.;Platt,R."ComparingapproachesforConfoundingAdjustmentinSecondaryDatabaseAnalyses:High-DimensionalPropensityScore versus two machine learning algorithms: Random Forest and Elastic Net", International Society for Clinical Biostatistics (ISCB) AnnualConference,21-25Aug2016Birmingham,UK(abstractsaccepted;stagepresentationscheduled)


66. Karim, M. E.; Petkau, J.; Gustafson, P.; Tremlett, H.; The BeAMS study group; "The Performance of Statistical Learning Approaches to ConstructInverseProbabilityWeightsinMarginalStructuralCoxModels:ASimulation-basedComparison",The3rdannualSSCStudentConference,DalhousieUniversity,Halifax,NovaScotia,June13,2015.

67. Karim, M. E.; Platt, R., Tremlett, H.; The BeAMS study group "Estimating Inverse Probability Weights using Super Learner whenWeight-ModelSpecification isUnknown inaMarginalStructuralCoxModelContext:AnApplicationtoMultipleSclerosis",sessionon"BiostatisticsApplications",AnnualMeetingoftheStatisticalSocietyofCanada,May29-June1,2016BrockUniversity,St.Catharines(abstractsaccepted;stagepresentationscheduled)

68. Karim, M. E.; Platt, R., Tremlett, H.; The BeAMS study group "Estimating Inverse Probability Weights using Super Learner whenWeight-ModelSpecification is Unknown in a Marginal Structural Cox Model Context: An Application to Multiple Sclerosis", XXVIIIth International BiometricConferenceVictoriaConventionCentre,Victoria,Canada10-15July,2016(abstractsaccepted;stagepresentationscheduled)

69. Khosrow-KhavarF,FilionKB,Al-QureshiS,TorabiN,BouganimN,SuissaS,AzoulayL.TheCardiovascularSafetyofAromataseInhibitorsandTamoxifeninPost-menopausalWomenwithBreastCancer:ASystematicReviewandMeta-AnalysisofRandomizedControlledTrials.AmericanSocietyofClinicalOncologyAnnualMeeting,Abstract/posternumber:1573,2016.PosterpresentationatASCO

70. Kraicer-MelamedH,O’DonnellS,QuachC*.TheIndirectEffectsofChildhoodPneumococcalConjugateVaccine(PCV)ProgramsonInvasivePneumococcalDisease(IPD)andCommunity-AcquiredPneumonia(CAP)inAdults:ASystematicReview(SP14).JAssocMedMicrobiolInfectDis2016;1:39***WinneroftheCanadianCollegeofMicrobiologists2016PosterAward(2016-AMMI-CACMIDAnnualConference)

71. KyleRP,MoodieEEM,AbrahamowiczM.Correctingmeasurementerrorintime-varyingcovariateswiththeSIMEXprocedure.AtlanticCausalInferenceConference,Philadelphia,PA,U.S.A.May20th,2015.

72. KyleRP,MoodieEEM,KleinMB,AbrahamowiczM.Applyingflexiblemodelingapproachestoaddressnon-linearityintime-varyingcovariates.AtlanticCausalInferenceConference,NewYork,NY,U.S.A.May26th,2016.

73. LabrecqueJA,BarrosAJD,BalzerLB,MaclehoseRF,StrumpfEC,KaufmanJS.Estimationoftheeffectofaconditionalcashtransferprogramonchildgrowthwithtargetedmaximumlikelihood(SER2016)

74. LabrecqueJA,KaufmanJS.InstrumentalVariableareRequiredforPositivity.(SER2016)75. LaurinLPetal.Treatmentwithglucocorticoidsorcalcineurininhibitorsinprimaryfocalsegmentalglomerulosclerosis.AmericanSocietyof

NephrologyRenalWeek2015asanoralpresentation(SA-OR020).76. LeeR.Fromoutbreaktoevolution:trackingMycobacteriumtuberculosisintheArctic.BiologyDepartmentSeminarSeries,UniversitédeMontréal,

Montréal,QC.Nov.2015(Invitedoralpresentation)77. LeeR.MultipleexposuresandriskofTBdisease.InfectiousDiseasesandImmunityinGlobalHealthResearchDay.Apr.2016(Oralpresentation)78. LeeR.TrackingTBintheCanadianArctic:DetectingoutbreaksamongFounderstrains.TheUnionAgainstTuberculosisandLungDisease–North

AmericanRegionConference.Denver,CO,USA.Feb.2016(Invitedoralpresentation).79. LeeR.TuberculosisinNunavik.InstitutNordiqueduQuébecResearchDay,QuébecCity,QC.Jun.2016(Invitedoralpresentation)80. LeeRS,ProulxJ-F,MenziesD,BehrMA.MultipleexposuresandriskofTBdisease.KeystoneSymposiaConference:TuberculosisCo-Morbiditiesand

Immunopathogenesis.Keystone,CO,USA.Feb.2016(Poster)**(GREATtravelawardaswellasInfectiousDiseasesandImmunityinGlobalHealthTravelaward)

81. LeeRS,ProulxJ-F,MenziesD,BehrMA.ProgressiontoactiveTBincreaseswithmultipleexposures.McGillInternationalTBCentreTraineeResearchDay,Montréal,QC.Jun.2015(Poster)**awardedfirstprize.

82. LevisAW,HarelD,KwakkenbosL,CarrierME,ThombsBD.UsingOptimalTestAssemblyMethodsforShorteningPatient-ReportedOutcomeMeasures:DevelopmentandValidationoftheCochinHandFunctionScale-6.OralPresentationatStatisticalSocietyofCanadaAnnualMeeting.May2016.BrockUniversity,St.Catharines,Ontario,Canada.


83. LevisB,BenedettiA,LevisAW,IoannidisJPA,ShrierI,CuijpersP,GilbodyS,KlodaLA,McMillanD,PattenSB,SteeleRJ,ZiegelsteinRC,BombardierCH,deLimaOsórioF,FannJR,GjerdingenD,LamersF,LotrakulM,LoureiroSR,LöweB,ShaabanJ,StaffordL,vanWeertHCPM,WhooleyMA,WilliamsLS,WittkampfKA,YeungAS,ThombsBD.SelectiveCutoffReportinginStudiesofDiagnosticTestAccuracy:AComparisonofConventionalandIndividualPatientDataMeta-AnalysesofthePatientHealthQuestionnaire-9DepressionScreeningTool.2016MethodsforEvaluatingMedicalTestsandBiomarkers(MEMTAB)Symposium,Birmingham,UnitedKingdom.July2016(peer-reviewedposterpresentation).

84. LevisB,BenedettiA,LevisAW,ThombsBD.SelectiveCutoffReportinginStudiesofDiagnosticTestAccuracy:AComparisonofConventionalandIndividualPatientDataMeta-AnalysesofthePatientHealthQuestionnaire-9DepressionScreeningTool.SeventhAnnualLadyDavisInstituteforMedicalResearchScientificRetreat.Montreal,Quebec.June2016(peer-reviewedposterpresentation).

85. LevisB,BenedettiA,LevisAW,ThombsBD.Selectivecutoffreportinginstudiesofdiagnostictestaccuracyofdepressionscreeningtools:Comparingtraditionalmeta-analysistoindividualpatientdatameta-analysis.SocietyforEpidemiologicResearch(SER)48thAnnualMeeting.Denver,Colorado,USA.June2015(peer-reviewedposterpresentation).

86. LevisB,BenedettiA,LevisAW,ThombsBD.Selectivecutoffreportinginstudiesofdiagnosticaccuracyofdepressionscreeningtools.AmericanPsychologicalAssociation(APA)AnnualConvention.Toronto,Canada.August2015(peer-reviewedposterpresentation).

87. LevisB,BenedettiA,LevisAW,ThombsBD.Selectivereportinginstudiesofdiagnostictestaccuracy:Comparingtraditionalmeta-analysistoindividualpatientdatameta-analysistoassessthediagnosticaccuracyofthePatientHealthQuestionnaire-9.Insymposium(BDThombs,Chair),Improvingevidence-basedpsychologicalservicesbyidentifyingandreducingreportingbiases.76thCanadianPsychologicalAssociationAnnualConvention.Ottawa,Ontario.June2015(peer-reviewedoralpresentation).

88. LevisB,BenedettiA,LevisAW,ThombsBD.Selectivereportinginstudiesofdiagnostictestaccuracy:Comparingtraditionalmeta-analysistoindividualpatientdatameta-analysistoassessthediagnosticaccuracyofthePatientHealthQuestionnaire-9.76thCanadianPsychologicalAssociationAnnualConvention.Ottawa,Ontario.June2015(peer-reviewedposterpresentation).

89. LevisB,BenedettiA,ThombsBD.Selectivecutoffreportingindiagnostictestaccuracystudiesofdepressionscreeningtools:Comparingtraditionalmeta-analysistoindividualpatientdatameta-analysis.2015CochraneColloquium.Vienna,Austria.October2015(peer-reviewedoralpresentation).

90. LevisB,BenedettiA,ThombsBD.Selectivecutoffreportinginstudiesofdiagnostictestaccuracyofdepressionscreeningtools:Comparingtraditionalmeta-analysistoindividualpatientdatameta-analysis.PreventingOverdiagnosis2015.Bethesda,Maryland,USA.September2015(peer-reviewedoralpresentation).

91. LevisB,KwakkenbosL,Coronado-MontoyaS,HudsonM,BaronM,ThombsBD.SociodemographicandDiseaseVariablesAssociatedwithFatigueinSystemicSclerosis. 2015,SclerodermaCanadaCongress.Hamilton,Ontario.September2015(peer-reviewedposterpresentation).

92. LevisB,KwakkenbosL,HudsonM,BaronM,ThombsBD.Fatigueinscleroderma:ACanadianSclerodermaResearchGroupstudyinvestigatingsociodemographicanddiseasecorrelates.4thSystemicSclerosisWorldCongress.Lisbon,Portugal.February2016(peer-reviewedposterpresentation).

93. LevisB,RiceDB,KwakkenbosL,SteeleR,HagedoornM,HudsonM,BaronM,ThombsBD,CanadianSclerodermaResearchGroup.Theroleofmaritalsatisfactioninemotionaldistressamongwomenwithsystemicsclerosis:Acomparisonofcontinuousvs.dichotomousmeasurementsofmaritalsatisfaction.2016EpidemiologyCongressoftheAmericas.Miami,Florida,USA.June2016(peer-reviewedposterpresentation).

94. LiL,FortinE,Ngenda-MuadiM,TremblayC,QuachC*.CentrallineAssociatedBloodtreamInfectionsinQuebecICUs:ResultsfromtheProvincialHealthcare-AssociatedInfectionsSurveillanceProgram(SPIN)(SP29).JAssocMedMicrobiolInfectDis2016;1:43.

95. LiL,FortinE,Ngenda-MuadiM,TremblayC,QuachC*.FacilityCharacteristicsIncorporationinStandardizedIncidenceRatiosforCLABSI(P18).JAssocMedMicrobiolInfectDis2016;1:56.

96. Lian,Y.InternationalSocietyforPharmacoepidemiology(ISPE)2016Mid-YearMeeting.Baltimore,MD,April2016.Selectedstudentoralpresentation


97. Lian,Y.DepartmentofEpidemiology,BiostatisticsandOccupationalHealthResearchDay.Montreal,QC,April2016.Selectedstudentoralpresentation

98. MagalhaesS.,BjornevikK.,MyhrKM.,PugliattiM.,RiiseT.,WolfsonC.(2015)CharacterizingSunExposureBehavioursinEarlyLifeUsingLatentVariableAnalyses:theEnvIMSStudy.EuropeanCommitteefortheTreatmentandResearchinMultipleSclerosis

99. MagalhaesS.,TanseyC.,BanwellB.,Bar-OrA.,FortierI.,HanwellH.,PugliattiM.,WolfsonC.(2015)Self-ReportofSunExposureBehavioursinPediatricResearch:ASystematicReviewofMeasurementProperties.CanadianSocietyofEpidemiologyandBiostatisticsMeeting.

100. MagalhaesS.,TanseyC.,BanwellB.,Bar-OrA.,FortierI.,HanwellH.,PugliattiM.,WolfsonC.(2015)BestPracticesforAssessingEnvironmentalTobaccoSmokeExposureinChildrenusingQuestionnaires:ASystematicReviewofMeasurementProperties.EuropeanCommitteefortheTreatmentandResearchinMultipleSclerosis.(selectedastoppostertobejudgedforaposterprize)

101. MarshallA,SaeedS.etal.,Areviewofrestrictionsforreimbursementofdirect-actingantiviraltreatmentforhepatitisCvirusinfectioninCanada.5thCanadianSymposiumonHepatitisCVirus,Montreal.February2016Oral

102. McDonaldEG,LeisJ,LeeT,SoongC.UpdatesinChoosingWiselyCanada,CanadianSocietyofInternalMedicine,CharlottetownPEI,October2015.103. McDonaldEG,ResearchinMedicalObstetrics:Wombforgrowth?CanadianSocietyofInternalMedicineresearchsummit,CharlottetownPEI,

October2015.104. McGregorK.April2015-PosterpresentationattheEBOH50thAnniversaryConference,MontrealQC.MethodsforestimatingchangesinDNA

methylationinthepresenceofcelltypeheterogeneity.105. McGregorK.MethodsforestimatingchangesinDNAmethylationinthepresenceofcelltypeheterogeneity.Contributedtalkandposter

presentationattheCanadianHumanandStatisticalGenetics,VancouverBCApril18-212015106. McLindenT,CoxJ,HamelinA-M,MoodieEEM,ParadisG,CooperC,GillJ,AnemaA,RourkeSB,WongL,KleinMB.Injectiondruguseisassociated

withfoodinsecurityinHIV-HCVco-infectedindividualsinCanada(CTN264)–asub-studyoftheCanadianCo-infectionCohort(CCC).AbstractEPHP9.03presentedatthe2016CanadianConferenceonHIV/AIDSResearch.Winnipeg,Manitoba.(Poster)

107. McLindenT,CoxJ,HamelinA-M.FoodSecurity&HIV-HCVSub-Study(CTN264)oftheCanadianCo-infectionCohort(CTN222).PresentedonNovember4,2015attheCIHRCanadianHIVTrialsNetwork(CTN)Fall2015Meetings.Montreal,Quebec.(OralPresentation)

108. McLindenT.RiskfactorsforfoodinsecurityinHIV-hepatitisCvirusco-infectedindividualsinCanada.PresentedApril19,2016attheAnnualCANOCRetreat(OntarioHIVTreatmentNetwork).Toronto,Ontario.(OralPresentation)

109. MoqueetN,KanagarathamC,RadziochD,SaeedS,PlattRW,KleinMB.DevelopingaPrognosticModelforSignificantLiverFibrosisinHIV-HepatitisC(HCV)Co-InfectedIndividualsfromtheCanadianCo-infectionCohortStudy.48thAnnualMeetingoftheSocietyforEpidemiologicResearch(SER2015).Denver,Colorado.16-19June,2015.(oralpresentation)

110. MoqueetN,KanagarathamC,RadziochD,SaeedS,PlattRW,KleinMB.DevelopingaPrognosticModelforSignificantLiverFibrosisinHIV-HepatitisC(HCV)Co-InfectedIndividualsfromtheCanadianCo-infectionCohortStudy.2016AnnualMeetingCanadianAssociationfortheStudyoftheLiver(CASL)/CDDW.February26-29,2016,Montreal,Quebec(oralpresentation)

111. MoqueetN,PlattR,HullM,CooperC,WalmsleyS,KleinMB,fortheCanadianCo-infectionCohort.FavourableIFNL3GenotypesandLiverFibrosisinHIV-HepatitisC(HCV)Co-InfectedIndividualsfromtheCanadianCo-InfectionCohort.24thAnnualCanadianConferenceonHIV/AIDSResearch(CAHR2015),Toronto,Ontario,April30–May3,2015.(oralposterdiscussion)

112. MoqueetN,PlattR,HullM,CooperC,WalmsleyS,KleinMB,fortheCanadianCo-infectionCohort.FavourableIFNL3GenotypesandLiverFibrosisinHIV-HepatitisC(HCV)Co-InfectedIndividualsfromtheCanadianCo-InfectionCohort.8thIASConferenceonHIVPathogenesis,TreatmentandPrevention.Vancouver,BritishColumbia.July19-22,2015.(poster)

113. MorrisonKT,ShaddickG,HendersonSB,BuckeridgeDL.Alatentprocessmodelforforecastingmultipletimeseriesinenvironmentalpublichealthsurveillance.'OralPresentationattheXXVIIIthInternationalBiometricConference.Victoria,BC.July10-15,2016.


114. MurphyT,JayS.Kaufman,NandiniDendukuri,ThomasCharters,ArijitNandi,SeungmiYang.ImpactofchildcarearrangementsonweightinQuebecpreschoolchildren.Postersessionpresentedat:SocietyforPediatricandPerinatalEpidemiologicResearch(SPER)29thannualmeeting;2016June20-21;Miami,Florida.

115. MurphyT,NandiniDendukuri,JayS.Kaufman,ThomasCharters,SeungmiYang.Bayesianregressionmodelsusingsurveyweights:asimulationstudyandcasestudyofchildcareandbodymassinQuebecchildren.Postersessionpresentedat:5thannualModernModelingMethodsconference;2016May24-25;Storrs,CT.

116. Murray,J.,Gaspar,F.,Bornman,R.,Crause,M.,Muvhulawa,O.,Barr,D.B.,Chevrier,J.ExposuretoDDTFollowingIndoorResidualSprayingandHypertensiveDisordersofPregnancyinSouthAfricanWomenParticipatingintheVHEMBEStudy.2015ConferenceoftheInternationalSocietyofEnvironmentalEpidemiology.SaoPaulo,Brazil.August2015.

117. Murray,J.,Gaspar,F.,Bornman,R.,Crause,M.,Muvhulawa,O.,Barr,D.B.,Chevrier,J.ExposuretoDDTFollowingIndoorResidualSprayingandHypertensiveDisordersofPregnancyinSouthAfricanWomenParticipatingintheVHEMBEStudy.2015ConferenceoftheCanadianSocietyforEpidemiologyandBiostatistics.Toronto,Canada.June2015.

118. OlagnierD . LD I r e t r e a t 2 016Montreal,Canada–June3,2016“Nrf2-mediatedautophagyincreasesoncolyticvirotherapybycurtailingantiviralinnateimmunity”

119. OlagnierD . CancerandAutoimmunity2016“Emergingtargetedtherapiesincancerandautoimmunity”Varadero,Cuba–April21-252016“Nrf2-mediatedautophagyincreasesoncolyticvirotherapybycurtailingantiviralinnateimmunity”

120. QianC.Riskofpneumoniainasthmapatientsusinginhaledcorticosteroids:Aquasi-cohortapproach.2016LDIRetreat,June3,2016,Montreal.121. RiehmKE,AzarM,ThombsBD.TransparencyofOutcomeReportingandTrialRegistrationinBehavioralHealthResearch:A5-YearFollow-up.In

Thombs,B.D.(Chair),Improvingevidence-basedpsychologicalservicesbyidentifyingandreducingreportingbiases(Symposium).CanadianPsychologicalAssociationConvention(CPA),Ottawa,Canada.June2015.

122. Riverin,B.AcademyHealthAnnualResearchMeeting2016,Boston*BestAbstractofAcademyHealthResearchMeeting,InvitedtopublishinHealthServicesResearch

123. Riverin,B.CanadianAssociationofHealthServicesandPolicyResearch2016AnnualConference,Toronto*CIHR-IHSPRBestStudentPosterAward(3rdplace)

124. Riverin,B.EpidemiologyCongressoftheAmericas,Miami(Poster)125. RossiC,CooperC,RaboudJ,AntoniouT,LoutfyM,TsoukasC,MachoufN,KleinMB.ViralHepatitisCo-InfectionandChronicKidneyDisease

ProgressionamongHIV-InfectedCanadiansInitiatingAntiretroviralTherapy.25thAnnualCanadianConferenceonHIV/AIDSResearch,13May2016,Winnipeg,Manitoba.(oralpresentation)

126. RossiC,CoxJ,CooperC,Martel-LaferriereV,GillJ,andKleinM.B.RatesandriskfactorsforhepatitisCre-infectionaftersustainedvirologicresponseinHIVco-infectedpatients.JournéedesÉtudiantsduRéseauSIDAetMaladiesInfectieuses,30thOctobre2015.(poster)

127. RossiC,HullM,CoxJ,CooperC,Martel-LaferrièreV,KleinMB.RatesandRiskFactorsforHepatitisCRe-InfectionorLateRelapseafterSustainedVirologicResponsetoTreatmentamongHIVCo-InfectedCanadians.25thAnnualCanadianConferenceonHIV/AIDSResearch,13May2016,Winnipeg,Manitoba.(oralpresentation)

128. RossiC,HullM,CoxJ,CooperC,Martel-LaferriereV,PickN,WalmsleySL,MontanerJS,KleinMB.RiskofHepatitisCVirusRe-InfectionorLateRelapseafterSustainedVirologicResponsetoInterferon-basedTherapyinHIVCo-infectedCanadians.5thCanadianSymposiumonHCV,Montreal,26February,2016.(oralpresentation)

129. RossiC,MoodieEEM,Rollet-KurhajecKC,CoxJ,CooperC,HullM,WalmsleyS,GillJ,RachlisA,andKleinMBfortheCanadianCo-infectionCohortStudyInvestigators.InjectionCocaineandRenalFunctionDeclineamongHCV-HIVCoinfectedPatients.19thWorkshoponHIVObservationalDatabases,Catania,Sicily,Italy.26-28thMarch2015.(poster)


130. RossiC,MoodieEEM,Rollet-KurhajecKC,CoxJ,CooperC,HullM,WalmsleyS,GillJ,RachlisA,andKleinMBfortheCanadianCo-infectionCohortStudyInvestigators.CocaineUseandChronicKidneyDiseaseinaHCV-HIVCo-InfectedCohort.24thAnnualCanadianConferenceonHIV/AIDSResearch(CAHR2015),Toronto,Ontario,April30–May3,2015.(oralposterdiscussion)

131. RossiC,MoodieEEM,Rollet-KurhajecKC,CoxJ,CooperC,HullM,WalmsleyS,GillJ,RachlisA,andKleinMBfortheCanadianCo-infectionCohortStudyInvestigators.InjectioncocaineuseasariskfactorforchronicrenalimpairmentamonghepatitisCandHIVco-infectedpatientsreceivingcare.48thAnnualSERMeeting,Denver,ColoradoJune16-19,2015.(oralpresentation)

132. S.Clark,L.Berrang-Ford,S.Lwasa,D.B.Namanya,K.Patterson,F.Twebaze,IHACCTeam,S.L.Harper.AcutegastrointestinalillnessinanAfricaIndigenouspopulation:ThelivedexperienceofUganda’sBatwa.TheInauguralForumonPopulationHealthEquity,atHarvardUniversity,Boston,USA,September2015.

133. SaeedSetal.Who'sgettingDirectActingAntiviralsinaCanadianHIV/HepatitisCCo-InfectedPopulation?5thCanadianSymposiumonHepatitisCVirus,Montreal.February2016(Winnerofbestclinicalsciencepresentation)

134. SaeedS,etal.HowgeneralizableareDirectAntiviralAgents(DAA)trialsforrealworldpeopleco-infectedwithHIV/HepatitisC?InternationalAIDSSociety,Vancouver,July2015Oral

135. ShapiroGD,KramerMS,KaufmanJS,BushnikT,SheppardAJ,WilkinsR,YangS.PaternaleducationandadversebirthoutcomesinCanada.SocietyforPediatricandPerinatalEpidemiologicResearchannualmeeting,Denver,June16,2015.

136. ShapiroGD,KramerMS,KaufmanJS,BushnikT,SheppardAJ,WilkinsR,YangS.MissingpaternaldataandadversebirthoutcomesinCanada.SocietyforEpidemiologicResearchannualmeeting,Denver,June18,2015.

137. ShapiroGD,SheppardAJ,BushnikT,KramerMS,KaufmanJS,YangS.All-causeandcause-specificinfantmortalityamongIndigenousCanadians.SocietyforPediatricandPerinatalEpidemiologicResearchannualmeeting,Miami,June20,2016.

138. SyrowatkaA,ChangS-L,MayoN,TamblynR,MeguerditchianAN.Psychotropicandnarcoticdruguseinolderwomendiagnosedwithbreastcanceracrossthecancercaretrajectory.Posterpresentationatthe2016EpidemiologyCongressoftheAmericasinMiami,FLonJune23rd,2016[accepted].

139. SyrowatkaA,KrömkerD,MeguerditchianAN,TamblynR.Featuresofcomputer-basedpatientdecisionaids:systematicreview,thematicsynthesis,andmeta-analyses.Invitedpodiumpresentationatthe2ndInternationalMeetingonWell-BeingandPerformanceinClinicalPracticeinChalkidiki,GreeceonMay20th,2016.

140. SyrowatkaA,KrömkerD,TamblynR.Canintegrationofmultimediafeaturesintodecisionaidsimprovepatientdecision-making?asystematicreviewandmeta-analysis.Podiumpresentationatthe37thAnnualNorthAmericanMeetingoftheSocietyforMedicalDecisionMakinginSt.Louis,MOonOctober19th,2015.

141. SyrowatkaA,KrömkerD,TamblynR.Interactivefeaturesthatcanbeintegratedintocomputer-baseddecision-aids:asystematicreviewandthematicanalysis.PodiumpresentationattheKnowledgeTranslationCanadaOpenScientificMeetinginHalifax,NSonMay12th,2015.

142. Turgeon,M.AnnualCanadianHumanandStatisticalGeneticsMeetinginVancouver,April2015143. Turgeon,M.AnnualMeetingoftheStatisticalSocietyofCanadainSt.Catharines,May2016144. WalzV.-Oralpresentation+posterattheIndigenousHealthConference(May26-272016)entitled“SkátneIonkwatehiahróntie’-“OurFamilies

GrowTogether”YoungParentsProgram”145. WongJAugust2015:PosterpresentationatISPE's31stInternationalConferenceonPharmacoepidemiology&TherapeuticRiskManagement,

Boston,MA.Title:"Polypharmacyandmultipleindicationsamongadultsprescribedantidepressants."AbstractpublishedinPharmacoepidemiologyandDrugSafety.2015;24(Suppl1):154-5.

146. WongJ.August2015:OralpresentationatISPE's31stInternationalConferenceonPharmacoepidemiology&TherapeuticRiskManagement,Boston,MA.Title:"Trendsinprescribingofantidepressantsfordepressionandoff-labelindications.”AbstractpublishedinPharmacoepidemiologyandDrugSafety.2015;24(Suppl1):398.


147. WongJ.June2016(abstractacceptedinJanuary2016):Oralpresentationatthe2016EpidemiologyCongressoftheAmericas,Miami,Florida.Title:"Usingdiagnosticcodesfromadministrativedatatodetermineantidepressanttreatmentindications:avalidationstudy.”

148. WusimanAibibula,JosephCox,Anne-MarieHamelin,HiroshiMamiya,MarinaBKlein,andPaulBrassard.FoodInsecurityandLowCD4CountAmongHIVInfectedPeople:ASystematicReviewandMeta-Analysis,CanadianAssociationforHIVResearch2016

149. WusimanAibibula,JosephCox,Anne-MarieHamelin,TaylorMcLinden,MarinaBKlein,andPaulBrassard.AssociationBetweenFoodInsecurityandHIVViralSuppression:ASystematicReviewandMeta-Analysis,CanadianAssociationforHIVResearch2016

150. WusimanAibibula,JosephCox,Anne-MarieHamelin,TaylorMcLinden,MarinaBKlein,andPaulBrassard.AssociationBetweenFoodInsecurityandHIVViralSuppression:ASystematicReviewandMeta-Analysis,CanadianSocietyforEpidemiologyandBiostatistics2016

151. YaoH,MagderS,McDonaldEG.HantavirusClinicalVignette.Posterpresentation,ABIM,May2016.152. ZongoS.,CarabaliM.,RiddeV.“Denguerapiddiagnostictest:atooltostrengthenhealthservicesandtoimprovedenguediagnosticsinBurkina

Faso”.22ndCanadianConferenceonGlobalHealth.Montreal,November5-7,2015.


AwardsNicholeAustin• 2016-2019:DoctoralAward($60,000)–FondsderechercheensantéduQuébec(FRQS)• 2015-2016:ICSTravelAward($1,500)–CanadianInstitutesofHealthResearch(CIHR)• 2015-2016:GraduateAward($4,000)–InstituteforHealthandSocialPolicy(IHSP)MarleineAzar• September2016-GraduateResearchEnhancementandTravel(GREAT)Award,McGillUniversity(750$)• June2016-CanadianInstitutesofHealthResearch(CIHR):TravelAwards-InstituteCommunitySupport• June2016(1,500$)May2016-BourseAndré-Lussier,Conférencelaurentiennederhumatologie.May2016(coversallcostsrelatedtotheconference)• September2016-August2017-FondsderechercheduQuébec-Santé:Formationdemaîtrise(15,000$+10,000$stipend)• September2015-Posterpresentationaward.2015SclerodermaNationalConference,SclerodermaSocietyofCanada,Hamilton,Ontario,Canada.• September2015.September2015-August2016–CanadianInstitutesofHealthResearch(CIHR):FredrickBantingandCharlesBestCanadaGraduate

ScholarshipsMaster’sAward(17,500$+7,500$stipend)• May-August2015–ScienceUndergraduateResearchAward(SURA)(6,000$)• May-August2015–NaturalSciencesandEngineeringResearchCouncilofCanadaUndergraduateStudentResearchAward(NSERCURSA)(declined;6,000$)LaurenceBrunet• TravelAward,TheCanadianNetworkforAdvancedInterdisciplinaryMethods(CAN-AIM)(2015)• TravelAward,CanadianInstitutesofHealthResearch(CIHR)(2016)MabelCarabali• TomlinsonDoctoralFellowship(35,000CAD/year).McGillUniversity.September2015HelenCerigo• DoctoralAward,CanadianInstitutesofHealthResearch(CIHR).FrederickBantingandCharlesBest,CanadaGraduateScholarship.(2016-2019,$35,000per

year)n 2015-2016:DavidG.GuthrieFellowship($12,000),McGillUniversity• 2015-2016:GraduateAward($4,000)–InstituteforHealthandSocialPolicy(IHSP)• 2016:ICSTravelAward($1,500)–CanadianInstitutesofHealthResearch(CIHR)• 2016TravelAward:LeRéseauderechercheensantédespopulationsduQuébec($1,500)


SierraClark• FondsdeRechercheduQuébec–Santé-Master’sTraininggrant(FRSQ-Masters)• FrederickBantingandCharlesBest(FBCB)CanadaGraduateScholarship-Master's(CGS-M)McGillUniversity• MitacsCanadaGlobalinkInternationalTravelAward.• CommitteeforResearchandExplorationoftheNationalGeographicSociety:YoungExplorersAward• NormanBethuneAwardforGlobalHealth,McGillUniversityFacultyofMedicineEvaGraham• CIHRtravelaward(forSERJune2016)• CIHRdoctoralaward• QueenElizabethScholarshipSoniaGrandi• FRSQDoctoralAward:$20,000/year2016-2018SophieGrand’Maison:• May2015:HonnormentionintheOralpresentation,clinicalpracticecategoryattheMcGillCardiovascularResearchDayforthepresentation:Withdrawal

fromtheWorkforceFollowingPrematureAcuteCoronarySyndrome:SexDifferencesandDeterminants• July2015:HaveaheartBurseryProgramAwardsoftheCanadianCardiovascularSocietyAcademyChristopherGravel• PostDoctoralMitacsaccelerateaward-"UtilizationofElectronicHealthRecordsforDrugSafetySignalRefinement"

ZoeGreenwald• FacultyofMedicine,InternalStudentshipaward• McGillIntegratedCancerResearchTrainingProgram• MitacsGlobalinkResearchAward• McBurneyLatinAmericanFellowship,McGillInstituteofHealthandSocialPolic

MohammedEhsanulKarim• American Journal of Epidemiology (AJE) and the Society for Epidemiologic Research (SER) selected my first-authored paper in AJE entitled “Marginal

StructuralCoxModelsforEstimatingtheAssociationBetweenbeta-InterferonExposureandDiseaseProgressioninaMultipleSclerosisCohort”asoneoftheJournal’s2014top10ArticlesoftheYear:awardedatSER’s48thAnnualMeetinginDenver,ColoradoonJune16-19,2015.

• Studentresearchpresentationsawardinthe2015annualStatisticalSocietyofCanada(SSC)Meeting($500)• RecipientofTravelawardfromtheStatisticalSocietyofCanada(SSC)BiostatisticsSection,2016($250)• Recipientsforthetravelawardfor2016CANSSIworkshop'StatisticalAnalysisofLargeAdministrativeHealthDatabases'($1,000)• StatisticsonReelsparticipationaward(CANSSI-sponsored)inthe2015StatisticalSocietyofCanada(SSC)StudentConference($100)


FarzinKhosrow-Khavar• NovartisOncologyYoungCanadianInvestigatorAward($5000)AdiKlil-Drori• 4thJuMPinHematology:JuniorMentoringProgramToronto,ON,May26-27,2016.AwardedonoffiveCanada-wideattendees.• IsraeliCancerResearchFund-Montreal.Fellowshipsupport$60,000CAD/yearfor2years.Supportforaclinicalfellowshipprograminthedepartmentof

Oncology,McGillUniversity,2016-2018.• TheCanadianVenousThromboEmbolismClinicalTrialsandOutcomesResearch(CanVECTOR).Fellowshipsupport$50,000CAD/yearfor1year.Fellowship,

clinicianinvestigatorstream,CanVECTORnetwork,2016-2017.• ConquerCancerFoundationandtheAmericanSocietyofClinicalOncology(ASCO),YoungInvestigatorAward.Researchgrant,$50,000USD/yearfor1year.

Forastudyentitled“TheUseofMetforminandtheIncidenceofLymphoidMalignanciesinPatientswithType2DiabetesMellitus.RyanKyle• StatisticalSocietyofCanada,BiostatisticsSection,TraineeTravelAward• Finalist,ReuelStallonesStudentPrizePaper,2016EpidemiologyCongressoftheAmericasBrookeLevis• DoctoralAward,CanadianInstitutesofHealthResearch(CIHR).FrederickBantingandCharlesBest,CanadaGraduateScholarship.(2016-2019,$35,000per

year)• AmericanPsychologicalAssociationEmergingLeadersinAssessmentAward,August2015.($250)• CanadianInstitutesofHealthResearch(CIHR)TravelAward,March2016.($1,500toattendtheEpidemiologyCongressoftheAmericasinMiami,Florida,

USA)• LadyDavisInstituteStudentTravelAward,August2015.($1,000toattendthe2015PreventingOverdiagnosisconferenceinBethesda,Maryland,USA)• McGillUniversityGraduateResearchEnhancementandTravel(GREAT)Award,June2015.($975toattendtheSocietyforEpidemiologicResearch(SER)

AnnualMeetinginDenver,Colorado,USA)

YiLian• DepartmentofEpidemiology,BiostatisticsandOccupationalHealthGraduateResearchEnhancementandTravel(GREAT)AwardEmilyG.McDonald• PloaDesforgesandEmilyG.McDonald.Insomniainthehospital:notjustabaddream.ClinicalvignettefirstplacewinneroftheLownInstituteRightCare

vignette competition, March 2016, Chicago, Illinois. Agency: CFN (Canadian Frailty Network) Type: Operating grant (co-principal applicant). Amount:$100000forpilotstudytobegininFall2016

• Agency:UniversityofToronto.Type:GeneralInternalMedicineresearchgrant.• Agency:UniversityofMcGillType:GeneralInternalMedicineresearchgrant


TaylorMcLinden• CIHRTravelAward-InstituteCommunitySupport,HIV/AIDSResearchInitiative.($2,500).CanadianInstitutesofHealthResearch.April2016.• GraduateResearchEnhancementandTravel(GREAT)Award.($850).McGillGraduateandPostdoctoralStudies.April2016.• CANOCCentreDoctoralScholarshipAward.($21,500).CanadianObservationalCohortCollaborationCentre&CIHRCanadianHIVTrialsNetwork.September

2015.LaylaMofid• ResultsDisseminationAwardfromtheRegroupementStratégiqueenSanteMondialeduRRSPQ

SalvatoreMottillo• 2016Firstplace,McGillEmergencyMedicineResearchDay• 2015Firstplace,QuébecAnnualDayforResearchinEmergencyMedicine(Amount:$500)• 2015Firstplace,AnnualMcGillCardiovascularResearchDay(Amount:$1,000)• 2015Secondplace,McGillEmergencyMedicineResearchDay(Amount:$100)JenMurray• FirstPlace,StudentPosterPresentation,"ExposuretoDDTfollowingIndoorResidualSprayingandhypertensivedisordersofpregnancyinSouthAfrican

womenparticipatingintheVHEMBEstudy”,2015CanadianSocietyforEpidemiologyandBiostatistics,May2015($150)• CIHRTravelAward($2500,August2015)DavidOlagnier

• 2015-McGillUniversityMedStarAward(CAN500)• 2015-2016-PeterQuinlanMcGillPostdoctoralFellowshipinOncology(CAN40,000/1year)2016-CanadianCancerSocietyTravelAward(CAN2000)BrunoRiverin• CIHR-ICSTravelAwardCarmineRossi• Bestposterprize,JournéedesÉtudiantsduRéseauSIDAetMaladiesInfectieuses(2015)• AcademicScholarship,CanadianAssociatonforHIVResearch(2016)SaharSaeed• DoctoralAward,FonddeRechercheSanteQuebec(FRQS),May2016:$60,000• BestClinicalSciencePresentation.5thSymposiumofHepatitisC.Feb2016:$500PauleyTedoff• 2015VanierCanadaGraduateScholarships• IHSPGraduateAwardProgram


VivienneWalz• GlobalEngagementSummitDelegate(April3-10,2016)0$700USDOpenShutterOutcomeAwardfortheSkátneIonkwatehiahróntie’YoungParents

Program• KnowledgeFirstFinancialPostgraduateAward(June2015)• ECOLEProject-CatalystAwardforConnectivity(April2016)JennaWong• MaxE.BinzFellowship,FacultyofMedicine,McGillUniversity($12,000)• MUHC-RIStudentshipandFellowshipaward(honorary)• BestanswerawardinCanadaHealthInfoway’sDataImpactIIChallenge($10,000).Awardwasforthequestiononunfilledprescriptions.

Documents

Spotlight on Student Research 2015-2016 - McGill University · PDF fileEBOH Spotlight on Student Research 2015-2016 Page 2 of 24 Publications 1. Acurcio FA , Machado MA, ... Scleroderma: